Neostigmine

CHEMBL278020 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

223.3 g/mol

LogP

1.5

Phase

4

This medication is used to treat myasthenia gravis, a disease causing muscle weakness, and to reverse muscle relaxation after surgery. It works by preventing the breakdown of acetylcholine, a chemical messenger that allows nerve signals to reach muscles, thereby improving muscle strength.

Peso Molecular

223,2900 g/mol

LogP

1,50

TPSA

29,50 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Bladder Cancer Cardiovascular Disease Pain Management Non-Small Cell Lung Cancer Chronic Obstructive Pulmonary Disease Anesthesiology Obesity Hypertension Breast Cancer Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1

InChI

InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1

Molecular Formula

C12H19N2O2+

HBD / HBA

- / 2

Ligações Rotacionáveis

3

Átomos Pesados

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This medication is used to treat myasthenia gravis, a disease causing muscle weakness, and to reverse muscle relaxation after surgery. It works by preventing the breakdown of acetylcholine, a chemical messenger that allows nerve signals to reach muscles, thereby improving muscle strength.

Yes, Neostigmine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL278020. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4456. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Neostigmine no PillFYI

Estrutura

Dados Rápidos

Fórmula: C12H19N2O2+
Sinônimos: 3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.